Pharmaceuticals, Biotechnology and Life Sciences
CAMBRIDGE, Mass.–(BUSINESS WIRE)–Dicerna™ Pharmaceuticals, Inc. (Nasdaq: DRNA) (the “Company” or “Dicerna”), a leading developer of investigational RNA interference (RNAi) therapeutics,…
AstraZeneca and Merck’s LYNPARZA Increased the Median Time Without Disease Progression or Death by 4.2 Months Versus Physician’s Choice of…
Three Independent Directors Nominated to Strengthen Board, Remove Conflicts and Return Control of the Company to Shareholders Commercial Potential of…
BROOKLYN, N.Y.–(BUSINESS WIRE)–Brooklyn ImmunoTherapeutics, a biopharmaceutical company focused on exploring the role that cytokine-based therapy can have in treating patients…
First engineered, GMP-grade, cryopreserved, off-the-shelf, bi-specific NK cell therapy to enter human clinical trials targeting CD16 and CD19 in patients…
Five-year follow-up analysis from Phase 1 CA209-004 study provides evidence of long-term survival following discontinuation of treatment in patients with…
HERCULES, Calif.–(BUSINESS WIRE)–Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb), a global leader of life science research and clinical diagnostic products,…
CATALIS’s public and private partners join forces to make Quebec a global leader in the conduct of early-stage clinical trials.…
More than 34% of survey participants agreed that enhanced point-of-prescribing tools to assist prescriber in identification is the most effective…
Veteran Public Affairs Campaign Executive Rich Masters to Join BIO in New Senior Position WASHINGTON–(BUSINESS WIRE)–BIO President & CEO Jim…